(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

ARGIFORM

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

ARGIFORM

ST13

US500000079074291

Classe

5, 10, 44

Pedido

79074291

Registro

3872962

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

56

Atualização mais recente

17/07/2022

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 10, 44

Data de depósito

25/05/2009

Data de registro

09/11/2010

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

21/05/2021

Última transação

21/05/2021

Escritório responsável

United States Patent and Trademark Office

Código da situação

709

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

98

Localização do titular

GB

Examinador

MICKLEBURGH, LINDA BOHANNON

Unidade examinadora

L60

Titulares e representantes

Titulares

BIOPHARMA DEVELOPMENT LTD.
BIOFORM INTERNATIONAL S.A.

Representantes

Jeffrery H. Greger Hauptman Ham, LLP

Classificação técnica

Classes Nice

Classe 5Classe 10Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Acaricides; acetates for pharmaceutical purposes; acids for pharmaceutical purposes; additives to fodder for medical purposes; adjuvants for medical purposes; alkaloids for medical purposes; medicinal alcohol; aldehydes for pharmaceutical purposes; algicides; albuminous foodstuffs for medical purposes; dietetic foods adapted for medical purposes; starch for dietetic or pharmaceutical purposes; amino acids for medical purposes; analgesics; anaesthetics; medicines for the treatment of rheumatisms or polyarthritismedicines spreading ring or delivery patchesanti-rheumatic drugsantibiotics; antiseptics; preparations for treatment of headaches; medical and surgical dressings for woundsfor burns and for surgeryself-adhesive or not; hygienic wound bandages; bandages for dressings; stick liquorice for pharmaceutical purposes; frostbite salve for pharmaceutical purposes; balms for medical purposes; bicarbonate of soda for pharmaceutical purposes; biocides; dietetic beverages adapted for medical purposes; medicated confectionery; bouillons for bacteriological culturesmedia for bacteriological cultures; magnetic bracelets for medical purposes; magnetic anti-rheumatism bracelets; bromine for pharmaceutical purposes; eye patches for medical purposes; cachets for pharmaceutical purposesvitamin tabletsantibiotic tabletsallergy tabletsdrug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; sedatives; capsules for medicines; caustics for pharmaceutical purposes; charcoal for pharmaceutical purposes; lint for dressings for medical purposes; hydrated chloral for pharmaceutical purposes; chloroform; bone cement for use in surgery and orthopedics; collodion for pharmaceutical purposes; eye-wash; nutritional additives for medical purposes; surgical compresses; headache pencils for medical purposes; wart pencils for medical purposes; caustic pencils for medical purposes; haemostatic pencils; cream of tartar for pharmaceutical purposes; creosote for pharmaceutical purposes; cultures of microorganisms for medical and veterinary use; curare for medical purposes; decoctions for pharmaceutical purposes; depuratives; diastase for medical purposes; digestives for pharmaceutical purposes; digitalin for medical purposes; drug delivery agents in the form of tabletscapsules or powderfor medical purposes; portable filled medicine cases for doctors and nurses; goulard water for use as astringent; melissa water for pharmaceutical purposes; sea water for medicinal bathing; mineral waters for medical purposes; thermal water; barks for pharmaceutical purposes; medical plasters; enzymes for medical purposes; dill oil for medical purposes; oil of turpentine for pharmaceutical purposes; esters for pharmaceutical purposes; cellulose esters for pharmaceutical purposes; ethers for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; eucalyptol for pharmaceutical purposes; eucalyptus for pharmaceutical purposes; extracts of hops for pharmaceutical purposes; linseed meal for pharmaceutical purposes; fishmeal for pharmaceutical purposes; flour for pharmaceutical purposes; febrifugesantipyretic analgesics; fennel for medical purposes; ferments for pharmaceutical purposes; milk ferments for pharmaceutical purposes; edible non-nutritive plant fibres for medical use; flowers of sulphur for pharmaceutical purposes; gelatine for medical purposes; petroleum jelly for medical purposes; royal jelly for medical purposes; gentian for pharmaceutical purposes; germicides; glucose for medical purposes; glycerine for medical purposesglycerophosphates; chewing gums for medical purposes; gum for medical purposes; gamboge for medical purposes; linseed for pharmaceutical purposes; greases for medical purposes; greases for veterinary purposes; haematogen; haemoglobin; hormones for medical purposes; oils for medical use; hydrastine; hydrastinine; surgical implants comprising living tissues; herbal infusions and tea for infusions for medical purposes; iodides for pharmaceutical purposes; isotopes for medical purposes; jalap as a purgative; lecithin for medical purposes; yeast for pharmaceutical purposes; liniments; skin and hair lotions for pharmaceutical purposes; serotherapeutic medicines; narcotics; nervines; ointments for pharmaceutical purposes; mercurial ointments; opiates for medical purposes; opium for medical purposes; opodeldoc for medical purposes; wadding for medical purposes; pastilles for pharmaceutical purposes; bacterial poisons for medical purposes; pomades for medical purposes; medicinal drinks; bacterial preparations for medical and veterinary use; bacteriological preparations for medical and veterinary purposes; biological preparations for medical purposes; chemical preparations for medical purposes; chemical preparations for pharmaceutical purposes; preparations of microorganisms for medical and veterinary use; vitamin preparations; enzyme preparations for medical purposes; medical preparations for slimming purposes; medicinal preparations for stimulating hair growth; preparations for bronchodilatorshaemorrhoid preparations; mothproofing preparationsmoth balls; anti-uric preparations; chemical-pharmaceutical preparations; opotherapy preparations; pharmaceutical preparations; pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical usefood for babies; plasters as materials for dressings; material for stopping teethdental wax; disinfectants ; preparations for destroying vermin; fungicidesherbicides; pharmaceutical preparations for skin carediagnostic preparations for medical purposes; radioactive substances for medical purposes; purgatives; medicinal roots; radium for medical purposes; chemical reagents for medical or veterinary purposes; tonics for medical purposesvitamins in the form of pills or vitamin supplement in tablet form for use in making an effervescent beverage when added to water; tranquillizers; salts for medical purposes; sera; syrups for pharmaceutical purposes; soporifics; steroids; dietetic substances adapted for medical use; nutritive substances for microorganisms; sugar for medical purposes; candy for medical purposes; milk sugar lactose for babies; sulphonamides as medicines; mineral food supplements; suppositories for medical purposes; tinctures for medical purposes; medicinal tea; tisanes for medical purposes; vaccines

Classe 10

Anaesthetic delivery apparatus; massage apparatus; surgical apparatus and instruments; surgicalmedicaldental and veterinary apparatus and instrumentsartificial limbseyes and teeth; orthopaedic articlesorthopaedic knee and articulation bandagesorthopaedic soles; suture materials; elastic bandages; anatomical bandages for joints; bandages and plaster bandages; artificial teeth; medicalsurgical and orthopaedic implants made of artificial materials; ocular prostheses; artificial breasts; suture materialsartificial skin for surgical purposes; containers for medical usebagspouchescartridgesrigid and semi-rigid containers for concentrates and solutions in solid or liquid form for medical use; medical wearing apparelshoes and orthopaedic footwear

Classe 44

Medical services; hygienic and beauty care for human beings; medical clinics; plastic surgery; chiropractics; hospital services; medical assistance; opticians' services; nursing homes with medical care; pharmacy advice; pharmacists' servicespreparing prescriptions

Publicações

Histórico de despachos e eventos da marca no USPTO.

56 publicações encontradas

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

17/07/2022

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

18/05/2022

INPC

INVALIDATION PROCESSED

18/05/2022

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

21/01/2022

C71T

CANCELLED SECTION 71

21/05/2021

REM4

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED

09/11/2019

RNWL

INTERNATIONAL REGISTRATION RENEWED

20/06/2019

NREP

NEW REPRESENTATIVE AT IB RECEIVED

24/05/2019

INNP

PARTIAL INVALIDATION PROCESSED BY THE IB

01/09/2017

INPS

PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

10/07/2017

INPC

INVALIDATION PROCESSED

10/07/2017

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

30/06/2017

NA71

NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED

31/10/2016

71.P

REGISTERED - PARTIAL SEC 71 ACCEPTED

31/10/2016

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

31/10/2016

ES71

TEAS SECTION 71 RECEIVED

12/09/2016

CHLD

CHANGE OF OWNER RECEIVED FROM IB

13/09/2013

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/08/2013

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

14/05/2013

INNA

INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE

14/05/2013

NREP

NEW REPRESENTATIVE AT IB RECEIVED

01/03/2013

INPR

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED

14/12/2011

FICS

FINAL DISPOSITION NOTICE SENT TO IB

28/03/2011

FIMP

FINAL DISPOSITION PROCESSED

28/03/2011

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

14/03/2011

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

17/02/2011

AMD7

SEC 7 REQUEST FILED

16/02/2011

ES7R

TEAS SECTION 7 REQUEST RECEIVED

16/02/2011

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

09/02/2011

R.PR

REGISTERED-PRINCIPAL REGISTER

09/11/2010

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

24/08/2010

PUBO

PUBLISHED FOR OPPOSITION

24/08/2010

CORN

CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED

04/08/2010

CRCV

CORRECTION TRANSACTION RECEIVED FROM IB

23/07/2010

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

22/07/2010

ALIE

ASSIGNED TO LIE

21/07/2010

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/07/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

28/06/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

28/06/2010

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

28/06/2010

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

21/04/2010

GNFR

FINAL REFUSAL E-MAILED

21/04/2010

CNFR

FINAL REFUSAL WRITTEN

21/04/2010

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

01/04/2010

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/04/2010

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/04/2010

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/04/2010

RFNP

REFUSAL PROCESSED BY IB

25/12/2009

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

24/11/2009

RFRR

REFUSAL PROCESSED BY MPU

24/11/2009

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

24/11/2009

CNRT

NON-FINAL ACTION WRITTEN

23/11/2009

MAFR

APPLICATION FILING RECEIPT MAILED

21/11/2009

DOCK

ASSIGNED TO EXAMINER

17/11/2009

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

17/11/2009

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

12/11/2009

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace ARGIFORM ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.